{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04083",
      "entity_text" : "ANXA1",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Cellular_component" : [ "go:GO:0018995" ]
    }
  },
  "verbose_text" : "Based on the oncogeneic effects of ANXA1 (promoting the proliferation, invasion and metastasis of ESCC cells), it may be conceivable to use miR-196a in the treatment of patients with ESCC who exhibit a high ANXA1 expression, as well as with a high risk of metastasis / recurrence.",
  "reading_complete" : "2020-08-03T17:47:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:47:01Z",
  "trigger" : "expression",
  "evidence" : [ "ANXA1 expression" ],
  "pmc_id" : "5358711",
  "score" : 0
}